Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …

Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

Background—Worldwide, atrial fibrillation is the most common arrhythmia, and its symptoms
and sequelae cause an enormous burden to patients and health systems. Stroke is …

Ischemic strokes related to atrial fibrillation are highly prevalent, presenting with severe
neurologic syndromes and associated with high risk of recurrence. Although advances have …

Background Non‐valvular atrial fibrillation (AF) is associated with an increased risk of stroke
mediated by embolism of stasis‐precipitated thrombi from the left atrial appendage …

Nonvalvular atrial fibrillation is a common rhythm disorder of middle-aged to older adults that
can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants …

Background The prevalence of atrial fibrillation (AF) is increasing globally, which is a major
clinical and public health concern due to the 5-fold increased risk of stroke. Oral …

Atrial fibrillation (AF) is the most common serious heart rhythm disorder, with a lifetime
incidence of 1 in 4 for patients> 40 years of age [1]. AF is a major cause of death and …

Importance Atrial fibrillation (AF) is associated with an increase in mortality and morbidity,
with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF …

Background The goal of this study was to compare the safety and effectiveness of individual
antiembolic interventions in nonvalvular atrial fibrillation (AF): novel oral anticoagulants …